Dr. Herman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Contra Costa Pl
Henderson, NV 89052Phone+1 512-422-6429
Summary
- Pharmaceutical Medicine, Digital Health, Mental Health Advocacy
Education & Training
- Tulane University/School of Public Health and Tropical MedicineMMM, Medical Managment, 1998
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Child and Adolescent Psychiatry, 1983 - 1985
- Alta Bates Summit Medical Center - Herrick campusResidency, Psychiatry, 1981 - 1983
- Tufts University School of MedicineClass of 1980
- University of Southern CaliforniaNon-degree, Pre-Med, 1973 - 1976
- Clark UniversityBA, Psychology, 1974
Certifications & Licensure
- CA State Medical License 1981 - 2027
- AR State Medical License 1985 - 2026
- PA State Medical License 2003 - 2026
- TX State Medical License 1989 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child Psychiatry
Awards, Honors, & Recognition
- Ronald Shellow Award American Psychiatric Association Assembly, 2022
- Administrative Psychiatry Award American Psychiatric Association, 2017
- American Psychiatric Association Recognition Award 2015
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSingle-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults:Barry K. Herman, Mohammed Bouhajib, Thomas R. King, Judith C. Kando, Antonio Pardo
Journal of Attention Disorders. 2021-04-01 - 1 citationsSingle-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension.Antonio Pardo, Judith C. Kando, Thomas R. King, Eman Rafla, Barry K. Herman
CNS Spectrums. 2020-01-22 - 6 citationsEarly-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity DisorderAnn C. Childress, Judith C. Kando, Thomas R. King, Antonio Pardo, Barry K. Herman
Journal of Child and Adolescent Psychopharmacology. 2019-01-25
Journal Articles
- Communication between Physicians and Patients with Suspected or Diagnosed Binge Eating DisorderKornstein, SG, Keck Jr., PE, Herman, BK, Puhl, RM, Wilfley, DE, DiMarco ID, Postgraduate Medicine, 1/1/2015
- The Psychological and Medical Factors Associated With Untreated Binge Eating DisorderSheehan DV, Herman BK, Prim Care Companion CNS Disord, 1/1/2015
- The Patient Experience with DSM-5-defined Binge Eating Disorder: Characteristics, Barriers to Treatment and Implications for Primary Care PhysiciansHerman, BK, Safikhani, S, Hengerer, D, Atkins, N, Kim, A, Cassidy, D, Babcock, T, Agus, S, Lenderking, W., Postgraduate Medicine, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Partnering with the Pharmaceutical IndustryHerman, BK, Fegert, JM, Baron, D., Turkish Journal of Psychiatry, 1/1/2006
- Ziprasidone vs Haloperidol for the Treatment of AgitationCitrome, L, Brook, S, Herman, BK, Loebel, A, Mandel, F, American Psychiatric Association Annual Meeting, Atlanta, GA, 1/1/2005
- Ziprasidone vs Haloperidol for the Treatment of AgitationCitrome, L, Brook, S, Herman, BK, Loebel, A, Mandel, F, Society for Biological Psychiatry, Atlanta, GA, 1/1/2005
- Join now to see all
Press Mentions
- Mentavi Health to Begin Screening for Binge Eating DisordersSeptember 28th, 2023
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: